This study was undertaken to evaluate the antifibrotic effect of anti-CXCR4 i-body AD-114 in kidney fibrosis and to elucidate the possible underlying mechanisms by utilizing the in vivo toxin-induced FA nephropathy model of CKD and the in vitro human PTC line. The gene discussed is CXCR4; the disease is chronic kidney disease.